24 May 2021 | News
Webinar set to explore Bio-analysis platforms which are most used in clinical trials to measure the level of inflammatory mediators in biological fluids.
Photo Credit: ACNNewswire
Australia's largest clinical trial and the most technologically advanced specialized bioanalytical laboratory, Agilex Biolabs, Inc., And analysis to share the latest techniques at a webinar by head of the immunoassay team at Agilex Biolabs.
“Inflammation refers to a complex biological process involving numerous resident and recruiting immune cells that are mobilized in a way that penetrates cells to counter invading pathogens. These immune cells are used to organize and regulate the immune response. With the mass production of inflammatory mediators that work in concert, the number of inflammatory mediators is rapidly increasing and moving actively Choosing a bioanalytical platform suitable for immunology clinical trials is critical to data collection, but dealing with complex inflammatory processes can be difficult. have."
In this webinar, Dr. Sales will look at how these platforms will look when using these platforms, as well as how to choose a suitable platform. Bio-analysis platforms are most used in clinical trials to measure the level of inflammatory mediators in biological fluids.
This webinar covers the contents of a custom 10 analyte inflammation panel using a COVID-19 (SARS-COV-2) virus sample, while the number of mediators observed in the body of a patient with COVID-19 infectious disease compared to the control group of non-infected patients. Webinar also discusses how these platforms use flow cytometry to measure specific immune factors in the body of clinical trial subjects.
May 25, 2:00 p.m. to 3:00 p.m., Eastern Time